NantHealth Inc reports results for the quarter ended in March - Earnings Summary

Nanthealth

07/05/2021 18:34

* NantHealth Inc  NH.OQ  reported a quarterly adjusted loss of 9
cents​​ per share for the quarter ended in March. The mean
expectation of two analysts for the quarter was for a loss of 7
cents per share.
* Revenue fell 11.1% to $16.17 million from a year ago​; 
analysts expected $18.33 million.
* NantHealth Inc's reported EPS for the quarter was a loss of 14
cents​.
* The mean earnings estimate of analysts had fallen by
about 7.1% in the last three months.​ 
* In the last 30 days there have been no earnings estimate
revisions by analysts covering the company. 
* NantHealth Inc shares had fallen by 21.8% this quarter and
lost 22.3% so far this year.
* The company reported a quarterly loss of $15.41 million.
* Wall Street's median 12-month price target for NantHealth Inc
is $3.75 
* The current average analyst rating on the shares is "strong
buy" and the breakdown of recommendations is 2 "strong buy" or
"buy," no "hold" and no "sell" or "strong sell." 
This summary was machine generated May 7 at 05:33 p.m. GMT. ​All
figures in US Dollars.​